🇺🇸 FDA
Patent

US 7514529

Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines

granted A61KA61K38/00A61K39/102

Quick answer

US patent 7514529 (Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61K39/102